Share of Cost, World’s first fluorescent sensor developed to detect date rape drug
Sunday, Jun. 15th 2014 6:00 AM
A team of researchers from the National University of Singapore (NUS) has developed the world’s first fluorescent sensor to identify the presence of a drug known as GHB that is commonly used to spike beverages. When the sensor is mixed with a sample of a beverage containing GHB, the mixture changes colour in less than 30 seconds, making detection of the drug fast and easy.
Related posts:
- Share of Cost: Low-Energy Wireless Sensor Networks For Greener Disaster Alerts New software allows wireless sensor networks to run at much lower energy, according to researchers writing in the International Journal of Sensor Networks. The technology could improve efficiency for hurricane and other natural disaster warning systems. Wireless sensor networks (WSNs) are used to monitor ecosystems, wild and urban environments....
- Share of Cost, FDA Approves New Multiple Sclerosis Drug Share of Cost, FDA Approves New Multiple Sclerosis Drug...
- Share of Cost, Study Shows Promise For New Drug To Treat Fragile X The first drug to treat the underlying disorder instead of the symptoms of Fragile X, the most common cause of inherited intellectual disability, shows some promise according to a new study published in the January issue of Science Translational Medicine. Researchers from Rush University Medical Center helped design the study and are now participating in […]...
- Share of Cost, Call For Hospitals To Establish Drug, Alcohol Tests For Physicians Share of Cost, Call For Hospitals To Establish Drug, Alcohol Tests For Physicians...
- Share of Cost, AIDS Drug Assistance Programs Managers Confront Uncertainty And Need To Adapt As The Affordable Care Act Kicks In Share of Cost, AIDS Drug Assistance Programs Managers Confront Uncertainty And Need To Adapt As The Affordable Care Act Kicks In ...
- Texas Share of Cost, Axanum And Expanded Nexium Indication Rejected By FDA Texas Share of Cost, Axanum And Expanded Nexium Indication Rejected By FDA: The Food and Drug Administration (FDA), USA has denied approval of AstraZeneca’s Axanum (aspirin plus esomeprazole magnesium) and an expanded indication for AstraZeneca’s Nexium (esomeprazole magnesium). AstraZeneca received a CRL (Complete Response Letter) for the new drug application for Axanum tablets, as well […]...
- Share of Cost, Bristol-Myers Squibb And ADAP Crisis Task Force Announce Enhanced, Multi-year Support For AIDS Drug Assistance Programs (ADAPs) In The United States Bristol-Myers Squibb Company (NYSE: BMY) and the ADAP Crisis Task Force (ACTF) announced an enhanced agreement to support the efforts of AIDS Drug Assistance Programs (ADAPs) to provide antiretroviral medicines to people living with HIV and AIDS....
- The Moral Case For The Routine Vaccination Of Children In Developed And Developing Countries The Moral Case For The Routine Vaccination Of Children In Developed And Developing Countries ...
- The Food And Drug Administration Gets New Tools To Spur Regulatory Science A new law that renews and extends user-fee arrangements for drug and device approvals also aims to speed effective new therapies to patients and the market....
- Share of Cost, Robot That Runs Like A Cat Has Implications For Search And Rescue Share of Cost, Robot That Runs Like A Cat Has Implications For Search And Rescue...
- Ten-Fold Increase Seen In Illicit Drug Use In 50- To 64-Year-Olds In England Since 1993 Ten-Fold Increase Seen In Illicit Drug Use In 50- To 64-Year-Olds In England Since 1993...
- Xofigo an Advanced Prostate Cancer Drug Approved By FDA Xofigo an Advanced Prostate Cancer Drug Approved By FDA ...
- By Training Bystanders to Spot Drug Overdoses May Reduce Deaths By Training Bystanders to Spot Drug Overdoses May Reduce Deaths...
- New Endoscopic Device To Detect Esophageal Cancer A tiny light source and sensors at the end of an endoscope may provide a more accurate way to identify pre-cancerous cells in the lining of the esophagus....
- Share of Cost, Fresh Funding Gives Hope To A New Generation Of Asthma And Allergy Treatment Share of Cost, Fresh Funding Gives Hope To A New Generation Of Asthma And Allergy Treatment...
Posted on Sunday, Jun. 15th 2014 6:00 AM | by Share of Cost | in Share of Cost | No Comments »